On May 21, 2024, Quest Diagnostics Incorporated announced that it held its annual general meeting of shareholders on May 16, 2024, and declared voting results. Accordingly, a shareholder proposal regarding managing climate risk through science-based targets and transition planning, submitted by John Chevedden, was not approved by the Company shareholders.